Tobaiqy, M.; MacLure, K.; Elkout, H.; Stewart, D.
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database. Vaccines 2021, 9, 1326.
https://doi.org/10.3390/vaccines9111326
AMA Style
Tobaiqy M, MacLure K, Elkout H, Stewart D.
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database. Vaccines. 2021; 9(11):1326.
https://doi.org/10.3390/vaccines9111326
Chicago/Turabian Style
Tobaiqy, Mansour, Katie MacLure, Hajer Elkout, and Derek Stewart.
2021. "Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database" Vaccines 9, no. 11: 1326.
https://doi.org/10.3390/vaccines9111326
APA Style
Tobaiqy, M., MacLure, K., Elkout, H., & Stewart, D.
(2021). Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database. Vaccines, 9(11), 1326.
https://doi.org/10.3390/vaccines9111326